Subcutaneous adipose tissue expression of plasminogen activator inhibitor-1 gene during very low calorie diet in obese subjects
- PMID: 10702753
- DOI: 10.1038/sj.ijo.0801087
Subcutaneous adipose tissue expression of plasminogen activator inhibitor-1 gene during very low calorie diet in obese subjects
Abstract
Objective: To determine whether changes in subcutaneous adipose tissue plasminogen activator inhibitor-1 (PAI-1) expression influence plasma PAI-1 level during weight loss in obese humans.
Design: Study of the variations of PAI-1 levels both in plasma and in subcutaneous abdominal adipose tissue in 15 volunteer non-diabetic obese subjects, body mass index (BMI) 40.4.+/-1.9 kg/m2, aged 48+/-3 y, before and after a 3 week very low calorie diet (VLCD) programme (3.9+/-0.1 MJ/day).
Measurements: Plasma and adipose tissue PAI-1 protein levels were measured by enzyme-linked immunosorbent assay and PAI-1 mRNA levels were quantified by quantitative RT-competitive PCR.
Results: VLCD induced weight loss (5.8+/-0.8 kg) and decreased plasma PAI-1 concentration (-26% (P<0. 01)). Surprisingly, PAI-1 mRNA and protein abundance in subcutaneous adipose tissue increased by 87% (P<0.05) and by 44% (P<0.01), respectively.
Conclusion: These data indicate thus that changes in subcutaneous adipose tissue PAI-1 expression are not involved in the decrease of plasma PAI-1 levels during VLCD in obese subjects. International Journal of Obesity (2000)24, 70-74
Similar articles
-
Subcutaneous abdominal, but not femoral fat expression of plasminogen activator inhibitor-1 (PAI-1) is related to plasma PAI-1 levels and insulin resistance and decreases after weight loss.Diabetologia. 2001 Nov;44(11):2025-31. doi: 10.1007/s001250100007. Diabetologia. 2001. PMID: 11719834
-
Subcutaneous adipose tissue expression of plasminogen activator inhibitor-1 (PAI-1) in nondiabetic and Type 2 diabetic subjects.Diabetes Metab Res Rev. 2000 Sep-Oct;16(5):364-9. doi: 10.1002/1520-7560(2000)9999:9999<::aid-dmrr148>3.0.co;2-c. Diabetes Metab Res Rev. 2000. PMID: 11025560
-
Peroxisome proliferator activated receptor-gamma, leptin and tumor necrosis factor-alpha mRNA expression during very low calorie diet in subcutaneous adipose tissue in obese women.Diabetes Metab Res Rev. 1999 Mar-Apr;15(2):92-8. doi: 10.1002/(sici)1520-7560(199903/04)15:2<92::aid-dmrr21>3.0.co;2-4. Diabetes Metab Res Rev. 1999. PMID: 10362456
-
The contribution of different adipose tissue depots to plasma plasminogen activator inhibitor-1 (PAI-1) levels.Blood Rev. 2016 Nov;30(6):421-429. doi: 10.1016/j.blre.2016.05.002. Epub 2016 May 19. Blood Rev. 2016. PMID: 27233154 Review.
-
Obesity and impaired fibrinolysis: role of adipose production of plasminogen activator inhibitor-1.Int J Obes Relat Metab Disord. 2004 Nov;28(11):1357-64. doi: 10.1038/sj.ijo.0802778. Int J Obes Relat Metab Disord. 2004. PMID: 15356668 Review.
Cited by
-
Plasminogen activator inhibitor-1 (PAI-1): a key factor linking fibrinolysis and age-related subclinical and clinical conditions.Cardiovasc Ther. 2010 Oct;28(5):e72-91. doi: 10.1111/j.1755-5922.2010.00171.x. Epub 2010 Jul 7. Cardiovasc Ther. 2010. PMID: 20626406 Free PMC article. Review.
-
Adipose tissue gene expression in obese subjects during low-fat and high-fat hypocaloric diets.Diabetologia. 2005 Jan;48(1):123-31. doi: 10.1007/s00125-004-1618-x. Epub 2004 Dec 29. Diabetologia. 2005. PMID: 15624093 Clinical Trial.
-
Plasminogen Activator Inhibitor-1 in poorly controlled vs well controlled Type-2 Diabetes Mellitus patients: A case-control study in a district hospital in Ghana.PLoS One. 2021 Apr 15;16(4):e0250090. doi: 10.1371/journal.pone.0250090. eCollection 2021. PLoS One. 2021. PMID: 33857223 Free PMC article.
-
Contribution of genetic and metabolic syndrome to omental adipose tissue PAI-1 gene mRNA and plasma levels in obesity.Obes Surg. 2010 Apr;20(4):492-9. doi: 10.1007/s11695-010-0079-1. Epub 2010 Feb 2. Obes Surg. 2010. PMID: 20127289
-
Coagulation and fibrinolysis abnormalities in obesity.J Endocrinol Invest. 2002 Nov;25(10):899-904. doi: 10.1007/BF03344054. J Endocrinol Invest. 2002. PMID: 12508953 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Miscellaneous